Occudo Quantitative Strategies LP Oncternal Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.86 - $22.2 $1,290 - $33,322	-1,501 Reduced 5.53%	25,620 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $108 - $241	-155 Reduced 0.57%	27,121 $30,000
Q4 2021 Feb 14, 2022	BUY	$2.27 - $4.39 $11,942 - $23,095	5,261 Added 23.9%	27,276 $62,000
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $20,284 - $28,650	6,019 Added 37.63%	22,015 $92,000
Q2 2021 Aug 16, 2021	BUY	$4.75 - $9.39 $21,009 - $41,531	4,423 Added 38.22%	15,996 $76,000
Q1 2021 May 14, 2021	BUY	$4.59 - $9.04 $53,120 - $104,619	11,573 New	11,573 $96,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.